Reply to thread

Why the surprise about watson as i reported here weeks ago they were ready willing and able?


And i was not surprised about pat's strong confidence in nacobal


Remember that generic succinate has captured only 50% of toprol family so even with watson there is potential and watson has approval for only 2 strengths


Today was a buying opportunity BIG TIME as we all forget about cash flow, the  balance sheet and that potent branded/ first to file pipeline



((((((($$ twenty soon)))))))